Symposium Introduction: Recommendations for a Biden/Harris Health Policy Agenda
This digital symposium explores recommendations for the Biden/Harris administration’s health policy agenda.
Government Regulation
-
Read more: Symposium Introduction: Recommendations for a Biden/Harris Health Policy Agenda -
Read more: Advancing a Public Health-Promoting National Opioid Policy Advancing a Public Health-Promoting National Opioid Policy
An American public health and safety-promoting drug policy agenda grounded in sound science is long overdue.
-
Read more: Bold Steps Needed to Correct Course in US Drug Policies Bold Steps Needed to Correct Course in US Drug Policies
Moving the United States beyond the opioid overdose crisis and pernicious inequities in law enforcement requires bold, innovative solutions.
-
Read more: It’s Time to Update the ACA’s Anti-Discrimination Protections It’s Time to Update the ACA’s Anti-Discrimination Protections
The Biden administration should work with Congress to add clearer nondiscrimination protections to the ACA.
-
Read more: Advantages of Using the Congressional Review Act to Revoke Health Care Waivers Advantages of Using the Congressional Review Act to Revoke Health Care Waivers
Revocations through the administrative process could undermine the stability of all waivers, but revocations through the CRA would not.
-
Read more: Questions for HHS Secretary Nominee Xavier Becerra Questions for HHS Secretary Nominee Xavier Becerra
Senators should expect clear answers on these questions from HHS Secretary Nominee Xavier Becerra before they consider confirming him.
-
Read more: New Regulation Aims at Accountability for Organ Procurement Organizations New Regulation Aims at Accountability for Organ Procurement Organizations
Recently finalized regulations seek to hold Organ Procurement Organizations (OPOs) more accountable for their performance.
-
Read more: Issuing the Most Favored Nation Interim Final Rule Was a Mistake Issuing the Most Favored Nation Interim Final Rule Was a Mistake
Procedurally, the Trump administration’s issuance of the Most Favored Nation Interim Final Rule was a mistake.
-
Read more: Short-Term, Limited-Duration Insurance May Be Here to Stay Short-Term, Limited-Duration Insurance May Be Here to Stay
Short-term, limited-duration insurance may be here to stay despite legal attacks, poor branding, and a potential Democrat victory in the upcoming election.
-
Read more: How Will Health Policy Change After COVID-19? How Will Health Policy Change After COVID-19?
COVID-19 highlights the importance of health policy change to socialize communicable disease costs, empower patients, and deregulate.
